Active Biotech AB (publ)

LSE:0GQU Stock Report

Market Cap: kr250.3m

Active Biotech Management

Management criteria checks 3/4

Active Biotech's CEO is Helen Tuvesson, appointed in Jul 2017, has a tenure of 5.58 years. total yearly compensation is SEK4.41M, comprised of 46.4% salary and 53.6% bonuses, including company stock and options. directly owns 0.051% of the company’s shares, worth SEK128.49K. The average tenure of the management team and the board of directors is 5.6 years and 3.3 years respectively.

Key information

Helen Tuvesson

Chief executive officer

kr4.4m

Total compensation

CEO salary percentage46.4%
CEO tenure5.6yrs
CEO ownership0.05%
Management average tenure5.6yrs
Board average tenure3.3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Helen Tuvesson's remuneration changed compared to Active Biotech's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2022n/an/a

-kr58m

Sep 30 2022n/an/a

-kr60m

Jun 30 2022n/an/a

-kr57m

Mar 31 2022n/an/a

-kr54m

Dec 31 2021kr4mkr2m

-kr50m

Sep 30 2021n/an/a

-kr38m

Jun 30 2021n/an/a

-kr35m

Mar 31 2021n/an/a

-kr32m

Dec 31 2020kr3mkr2m

-kr32m

Sep 30 2020n/an/a

-kr39m

Jun 30 2020n/an/a

-kr40m

Mar 31 2020n/an/a

-kr36m

Dec 31 2019kr3mkr2m

-kr34m

Sep 30 2019n/an/a

-kr32m

Jun 30 2019n/an/a

-kr31m

Mar 31 2019n/an/a

-kr35m

Dec 31 2018kr3mkr1m

-kr37m

Sep 30 2018n/an/a

-kr88m

Jun 30 2018n/an/a

-kr88m

Mar 31 2018n/an/a

-kr103m

Dec 31 2017kr2mkr1m

-kr109m

Compensation vs Market: Helen's total compensation ($USD422.50K) is about average for companies of similar size in the UK market ($USD348.42K).

Compensation vs Earnings: Helen's compensation has increased whilst the company is unprofitable.

CEO

Helen Tuvesson (60 yo)

5.6yrs

Tenure

kr4,409,000

Compensation

Ms. Helen Tuvesson, Ph.D. is President of Active Biotech AB and its Chief Executive Officer since 2017. She serves as Independent Director at Mendus AB (publ) (formerly known as Immunicum AB (publ)) since...

Leadership Team

NamePositionTenureCompensationOwnership
Helen Tuvesson
President & CEO5.6yrskr4.41m0.051%
SEK 128.5k
Hans Kolam
Chief Financial Officer23.1yrsno data0.057%
SEK 143.2k
Erik Vahtola
Chief Medical Officer1.1yrsno data0.017%
SEK 42.2k

5.6yrs

Average Tenure

Experienced Management: 0GQU's management team is seasoned and experienced (5.6 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Peter Thelin
Independent Director11.8yrskr209.00k1.36%
SEK 3.4m
Uli Hacksell
Independent Director3.8yrskr203.00kno data
Michael Shalmi
Independent Chairman of the Board3.8yrskr521.00k0.13%
SEK 318.2k
Elaine Sullivan
Independent Director2.8yrskr200.00kno data
Axel Glasmacher
Independent Director2.8yrskr205.00kno data
Aleksandar Danilovski
Independent Director2.8yrskr207.00k0.050%
SEK 126.0k

3.3yrs

Average Tenure

61.5yo

Average Age

Experienced Board: 0GQU's board of directors are considered experienced (3.3 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.